{"eventGroups":[{"deathsNumAffected":22,"deathsNumAtRisk":26,"description":"Lenalidomide 25 mg administered orally once daily (QD) until progressive disease or unacceptable toxicity","id":"EG000","otherNumAffected":26,"otherNumAtRisk":26,"seriousNumAffected":11,"seriousNumAtRisk":26,"title":"Lenalidomide"}],"frequencyThreshold":"5","otherEvents":[{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA (15.1)","stats":[{"groupId":"EG000","numAffected":20,"numAtRisk":26}],"term":"Thrombocytopenia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA (15.1)","stats":[{"groupId":"EG000","numAffected":19,"numAtRisk":26}],"term":"Neutropenia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA (15.1)","stats":[{"groupId":"EG000","numAffected":18,"numAtRisk":26}],"term":"Lymphopenia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA (15.1)","stats":[{"groupId":"EG000","numAffected":15,"numAtRisk":26}],"term":"Anaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA (15.1)","stats":[{"groupId":"EG000","numAffected":13,"numAtRisk":26}],"term":"Leukopenia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA (15.1)","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":26}],"term":"Leukocytosis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA (15.1)","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":26}],"term":"Basophilia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA (15.1)","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":26}],"term":"Eosinophilia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA (15.1)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":26}],"term":"Disseminated intravascular coagulation"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA (15.1)","stats":[{"groupId":"EG000","numAffected":9,"numAtRisk":26}],"term":"Hypoalbuminaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA (15.1)","stats":[{"groupId":"EG000","numAffected":9,"numAtRisk":26}],"term":"Hypoproteinaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA (15.1)","stats":[{"groupId":"EG000","numAffected":8,"numAtRisk":26}],"term":"Hypocalcaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA (15.1)","stats":[{"groupId":"EG000","numAffected":9,"numAtRisk":26}],"term":"Hyponatraemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA (15.1)","stats":[{"groupId":"EG000","numAffected":9,"numAtRisk":26}],"term":"Hypophosphataemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA (15.1)","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":26}],"term":"Hypokalaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA (15.1)","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":26}],"term":"Hyperkalaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA (15.1)","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":26}],"term":"Hyperchloraemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA (15.1)","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":26}],"term":"Hypouricaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA (15.1)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":26}],"term":"Decreased appetite"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA (15.1)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":26}],"term":"Dehydration"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA (15.1)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":26}],"term":"Hyperglycaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA (15.1)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":26}],"term":"Hyperuricaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA (15.1)","stats":[{"groupId":"EG000","numAffected":11,"numAtRisk":26}],"term":"C-reactive protein increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA (15.1)","stats":[{"groupId":"EG000","numAffected":8,"numAtRisk":26}],"term":"Alanine aminotransferase increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA (15.1)","stats":[{"groupId":"EG000","numAffected":7,"numAtRisk":26}],"term":"Aspartate aminotransferase increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA (15.1)","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":26}],"term":"Blood alkaline phosphatase increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA (15.1)","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":26}],"term":"Blood urea increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA (15.1)","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":26}],"term":"Blood creatinine increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA (15.1)","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":26}],"term":"Differential white blood cell count abnormal"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA (15.1)","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":26}],"term":"Glucose urine present"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA (15.1)","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":26}],"term":"Blood lactate dehydrogenase increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA (15.1)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":26}],"term":"Blood urine present"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA (15.1)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":26}],"term":"Neutrophil count decreased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA (15.1)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":26}],"term":"Weight decreased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA (15.1)","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":26}],"term":"Rash"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA (15.1)","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":26}],"term":"Pruritus"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA (15.1)","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":26}],"term":"Rash maculo-papular"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA (15.1)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":26}],"term":"Drug eruption"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA (15.1)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":26}],"term":"Dry skin"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (15.1)","stats":[{"groupId":"EG000","numAffected":8,"numAtRisk":26}],"term":"Constipation"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (15.1)","stats":[{"groupId":"EG000","numAffected":7,"numAtRisk":26}],"term":"Nausea"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (15.1)","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":26}],"term":"Vomiting"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (15.1)","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":26}],"term":"Stomatitis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (15.1)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":26}],"term":"Diarrhoea"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (15.1)","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":26}],"term":"Nasopharyngitis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (15.1)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":26}],"term":"Pneumonia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (15.1)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":26}],"term":"Upper respiratory tract infection"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA (15.1)","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":26}],"term":"Malaise"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA (15.1)","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":26}],"term":"Fatigue"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA (15.1)","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":26}],"term":"Pyrexia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA (15.1)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":26}],"term":"Oedema peripheral"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA (15.1)","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":26}],"term":"Back pain"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA (15.1)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":26}],"term":"Muscle spasms"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (15.1)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":26}],"term":"Dyspnoea"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (15.1)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":26}],"term":"Upper respiratory tract inflammation"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA (15.1)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":26}],"term":"Bradycardia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA (15.1)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":26}],"term":"Supraventricular extrasystoles"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA (15.1)","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":26}],"term":"Hepatic function abnormal"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA (15.1)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":26}],"term":"Hyperbilirubinaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (15.1)","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":26}],"term":"Neuropathy peripheral"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (15.1)","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":26}],"term":"Dysgeusia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA (15.1)","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":26}],"term":"Tumour flare"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA (15.1)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":26}],"term":"Phlebitis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA (15.1)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":26}],"term":"Contusion"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA (15.1)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":26}],"term":"Fall"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA (15.1)","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":26}],"term":"Insomnia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Immune system disorders","sourceVocabulary":"MedDRA (15.1)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":26}],"term":"Hypogammaglobulinaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA (15.1)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":26}],"term":"Proteinuria"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA (15.1)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":26}],"term":"Eosinophil count increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA (15.1)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":26}],"term":"Basophil count increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA (15.1)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":26}],"term":"Blood albumin decreased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA (15.1)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":26}],"term":"Haemorrhage subcutaneous"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA (15.1)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":26}],"term":"Toxic skin eruption"}],"seriousEvents":[{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA (15.1)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":26}],"term":"Erythema multiforme"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA (15.1)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":26}],"term":"Rash"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA (15.1)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":26}],"term":"Toxic skin eruption"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA (15.1)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":26}],"term":"Thrombocytopenia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA (15.1)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":26}],"term":"Anaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA (15.1)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":26}],"term":"Non-cardiac chest pain"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA (15.1)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":26}],"term":"Pyrexia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (15.1)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":26}],"term":"Enterocolitis infectious"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (15.1)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":26}],"term":"Meningitis bacterial"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (15.1)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":26}],"term":"Pneumonia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (15.1)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":26}],"term":"Syncope"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (15.1)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":26}],"term":"Transient ischaemic attack"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA (15.1)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":26}],"term":"Acute left ventricular failure"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Ear and labyrinth disorders","sourceVocabulary":"MedDRA (15.1)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":26}],"term":"Vertigo positional"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA (15.1)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":26}],"term":"Acute hepatic failure"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA (15.1)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":26}],"term":"Blood pressure decreased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA (15.1)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":26}],"term":"Tumour flare"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA (15.1)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":26}],"term":"Renal failure acute"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (15.1)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":26}],"term":"Pulmonary oedema"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDra 15.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":26}],"term":"Sinusitis fungal"}],"timeFrame":"From the first day of lenalidomide treatment through 28 days after the last dose of lenalidomide. up to clinical cut-off date of 19 May 2017; maximum duration of study drug was 130.4 weeks"}